제약회사 영업사원의 면담 품질(Call Quality) 향상을 위한 퍼실리테이션(Facilitation) 교육법의 효과
The Effectiveness of Facilitation Education for Call Quality of Medical Representative in Pharmaceutical Industry
0
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Objectives: The purpose of this study is to figure out that Facilitation education can affect significant improvement in sales staff’s understanding of precise pharmacokinetics, benefits, safety, and side effects, etc. and eventually lead to increase in call after taking courses. Methods: Data utilized in this study was collected from 413 sales staffs who completed Facilitation course for 5 months. This study used statistical methodologies, paired t-test, exploratory factor analysis, and logistic regression model in order to identify change in Call and after Facilitation courses. Results: The result shows that there are statistically significant increases in CALL quality after Facilitation courses based on the result of pared t-test. Moreover, Facilitation education is more effective in average time of one-time detail than average number of visits per day and average number of doctors per day from the result of logistic regression. Conclusions: In order for MR in pharmaceutical company to improve CALL quality, the education for precise pharmacokinetics, benefits, safety, and side effects is necessary. In addition, various professional training required for detail, including disease education, Selling Skills education, and literacy education are essential. Therefore, Facilitation education would be desirable choice in terms of pharmaceutical marketing strategy.
Abstract
Objectives: The purpose of this study is to figure out that Facilitation education can affect significant improvement in sales staff’s understanding of precise pharmacokinetics, benefits, safety, and side effects, etc. and eventually lead to increase in call after taking courses. Methods: Data utilized in this study was collected from 413 sales staffs who completed Facilitation course for 5 months. This study used statistical methodologies, paired t-test, exploratory factor analysis, and logistic regression model in order to identify change in Call and after Facilitation courses. Results: The result shows that there are statistically significant increases in CALL quality after Facilitation courses based on the result of pared t-test. Moreover, Facilitation education is more effective in average time of one-time detail than average number of visits per day and average number of doctors per day from the result of logistic regression. Conclusions: In order for MR in pharmaceutical company to improve CALL quality, the education for precise pharmacokinetics, benefits, safety, and side effects is necessary. In addition, various professional training required for detail, including disease education, Selling Skills education, and literacy education are essential. Therefore, Facilitation education would be desirable choice in terms of pharmaceutical marketing strategy.
참고문헌 (22)
- 차재빈, "제약회사의 내부마케팅활동과 직무만족, 조직몰입, 이직의도와의 관계 -제약영업사원을 중심으로-", 보건의료산업학회지, 7(1), pp.69~82 (2013), 보건의료산업학회
- Employment Trends in the Health Industry in Q1, , KHIDI Korea Health Industry Development Institute, 7~9 (2018)
- 배을규, "제약회사 영업사원의 셀프 리더십과 변화 몰입의 관계에서 잡 크래프팅의 매개효과", 평생교육 · HRD연구, 15(2), pp.125~151 (2019), 한국평생교육ㆍHRD연구소[DOI]
- H.S. Im, "Sales and Marketing Strategies of IMD (Incrementally Modified Drugs) Cilostazole", Master, pp.2016
- T. Blackshear, "The Impact of Adaptive Selling on Sales Effectiveness Within the Pharmaceutical Industry", Journal of Marketing Theory and Practice, 2(3), pp.106~125 (1994)
- C.H. Jung, "A randomized, double-blind, placebo-controlled, phase II clinical trial to investigate the efficacy and safety of oral DA-1229 in patients with type 2 diabetes mellitus who have inadequate glycaemic control with diet and exercise", Diabetes, 2015, pp.31(3), 295~306
- E. Sanchez-Rangel, "Metformin: clinical use in type 2 diabetes", Diabetologia, 60(9), pp.1586~1593 (2017)
- J.A. Hirst, "Estimating the effect of sulfonylurea on HbA1c in diabetes: a systematic review and meta-analysis", Diabetologia, 56(5), pp.973~984 (2013)
- D.S. Hsia, "An Update on SGLT2 Inhibitors for the Treatment of Diabetes Mellitus, Current Opinion in Endocrinology", Diabetes and Obesity, 24(1), pp.73~79 (2017)
- W.L. Bennett, "Comparative Effectiveness and Safety of Medications for Type 2 Diabetes: An Update Including New Drugs and 2-Drug Combinations", Annals of Internal Medicine, 154(9), pp.602~613 (2011)
- S.M. Hong, "Efficacy and safety of adding evogliptin versus sitagliptin for metformin-treated patients with type 2 diabetes: A 24-week randomized, controlled trial with open label extension", Diabetes, Obesity and Metabolism, 19(5), pp.654~663 (2017)
- E. Bosi, "Vildagliptin plus metformin combination therapy provides superior glycaemic control to individual monotherapy in treatment-naive patients with type 2 diabetes mellitus", Diabetes, Obesity and Metabolism, 11(5), pp.506~515 (2009)
- M. Jadzinsky, "Saxagliptin given in combination with metformin as initial therapy improves glycaemic control in patients with type 2 diabetes compared with either monotherapy: a randomized controlled trial", Diabetes, Obesity and Metabolism, 11(5), pp.611~622 (2009)
- P-H. Groop, "Linagliptin treatment in subjects with type 2 diabetes with and without mild-to-moderate renal impairment", Diabetes, Obesity and Metabolism, 16(6), pp.560~568 (2014)
- H.J. Kim, "Efficacy and Safety of Switching to Teneligliptin in Patients with Type 2 Diabetes Inadequately Controlled with Dipeptidyl Peptidase-4 Inhibitors: A 12-Week Interim Report", Diabetes Therapy, 10(4), pp.1271~1282 (2019)
- N. Gu, "Multiple-dose pharmacokinetics and pharmacodynamics of evogliptin (DA-1229), a novel dipeptidyl peptidase IV inhibitor, in healthy volunteers", Drug Design, Development and Therapy, 8, pp.1709~1721 (2014)
- 김미경, "Prevention and treatment effect of evogliptin on hepatic steatosis in high-fat-fed animal models", Archives of Pharmacal Research, 40(2), pp.268~281 (2017), 대한약학회
- H.K. Lee, "Unique binding mode of Evogliptin with human dipeptidyl peptidase IV", Biochemical and Biophysical Research Communications, 494(3-4), pp.452~459 (2017)
- 최일선, "Two Perspectives on Facilitation in Adult Education: Learner-centered Facilitation versus Interventionist Facilitation", Andragogy Today: Interdisciplinary Journal of Adult & Continuing Education (IJACE), 12(3), pp.103~129 (2009), 한국성인교육학회[DOI]
- 최창진, "임상실습을 마친 의대생의 환자 중심적 의사소통 기술과 태도", Korean Journal of Medical Education, 16(2), pp.169~178 (2004), 한국의학교육학회
- H.S. Im, "Site of Pharmaceutical Bio Industry", pp.204~211 (2018), Naeha publishing company